Dihydromyricetin 50 g | 98%
Nature Science Technologies Ltd
Dihydromyricetin
Search Results
(±)13,14-EDT 500 µg | ≥98%
Cayman Chemical
(±)13,14-EDT
(±)13(14)-DiHDPA 1 mg | ≥98%
Cayman Chemical
(±)13(14)-DiHDPA
(±)13(14)-DiHDPA 1 mg | Purity Not Available
TargetMol
(±)13(14)-DiHDPA is a metabolite of docosahexaenoic acid that is produced via oxidation by cytochrome P450 epoxygenases. Epoxygenase metabolites of DHA, including (±)13(14)-DiHDPA, are reported to inhibit angiogenesis, tumor growth, and metastasis.
More Information Supplier Page(±)13(14)-DiHDPA
(±)13(14)-DiHDPA 500 µg | ≥98%
Cayman Chemical
(±)13(14)-DiHDPA
(±)13(14)-DiHDPA 100 µg | ≥98%
Cayman Chemical
(±)13(14)-DiHDPA
(±)13(14)-DiHDPA 50 µg | ≥98%
Cayman Chemical
(±)13(14)-DiHDPA
(±)13(14)-EpDPA 1mg | ≥98%
Musechem
(±)13(14)-EpDPA 500 µg | ≥95%
Cayman Chemical
(±)13(14)-EpDPA
(±)13(14)-EpDPA 100 µg | ≥95%
Cayman Chemical
(±)13(14)-EpDPA
(±)13(14)-EpDPA 50 µg | ≥95%
Cayman Chemical
(±)13(14)-EpDPA